Wednesday, 20th February 2019

Molecular Neuropathology

    Role of Lipids in Neuronal Physiology and Pathology

 

 

 grupo400

 


 

 

María Dolores Ledesma

 

DSciStaff

 

DPublications 

 

 

 

 

 

Research summary: 

 

 
 fig01

The figure exemplifies the drastic effects that changes in sphingolipid levels have in synapses. Electron microscopy analysis in the hippocampus of age-matched wild type and acid sphingomyelinase knockout mice evidence a significant size reduction of the pre and postsynaptic compartments in the mutant animals, which show high levels of sphingomyelin and its derivatives.

Our laboratory is interested in understanding the role of lipids in neuronal physiology and pathology focusing on their participation in synapses. In recent years our knowledge about the protein machinery that controls synaptic transmission has greatly increased. However, much less is known about the contribution of lipids to this process despite the fact that binding to the membrane, of which lipids are major components, modulates the activity of essential synaptic proteins. Moreover, synaptic transmission relies on membrane dynamics. The observation that most lipidosis lead to cognitive impairment and mental retardation further support the relevance of lipids in such process. We focus in the analysis of sphingolipids and cholesterol because, among other reasons, they are particularly enriched in neurons and have the ability to form signalling platforms. As experimental models we use mice in which enzymes related to lipid metabolism have been genetically altered allowing in vivo analysis. At present we study mice deficient in the acid sphingomyelinase and in seladin1, which participate in sphingomyelin turnover and cholesterol synthesis, respectively. These mice mimic human genetic diseases, such as Niemann pick type A and desmosterolosis, which cause severe mental retardation. Interestingly, the lipidic alterations we have found in these mice (Crameri et al., EMBO J, 2006; Galvan et al., Mol. Biol. Cell, 2008) are similar to those reported in aging brains. This opens the possibility that our results will have implications not only in the establishment and maintenance of synapses but also in their functional decay during aging. Therefore, we hope our work will contribute to understand neurological diseases in childhood as well as neurodegenerative disorders like Alzheimer's disease.

 


 

Relevant publications:

A. Crameri, E. Biondi, K. Kuehnle, D. Lütjohann, K.M. Thelen, S. Perga,C.G. Dotti, R. M. Nitsch, M.D. Ledesma*, M. H. Mohajeri*.“Seladin-1/DHCR24 role in cholesterol biosynthesis, APP processing and Abgeneration in vivo”. (2006) EMBO J. 25:432-443. *corresponding authors

C. Galvan, P.G. Camoletto, F. Cristofani, P.P. Van Veldhoven, M.D Ledesma. “Anomalous surface distribution of GPI-anchored proteins in neurons lacking acid sphingomyelinase”. (2008) Mol. Biol. Cell. 19: 509-522.

P.G.Camoletto, H.Vara, L.Morando, E.Connell, F.P. Marletto, M.Giustetto, M.Sassoé-Pognetto, P.P.Van Veldhoven, M.D. Ledesma. "Synaptic vesicle docking: sphingosine regulates syntaxin1 interaction with Munc18" (2009) PLoS One 4(4): e5310.

M.D. Ledesma, M.G. Martin, C.G. Dotti. Lipid changes in the aged brain: effect on synaptic function and neuronal survival. (2012) Prog. Lipid Res. 51: 23-35.

A.I. Arroyo, P.G. Camoletto, L. Morando, M. Sassoe-Pognetto, M. Giustetto, P.P. Van Veldhoven, E.H. Schuchman, M.D. Ledesma “Pharmacological reversion of sphingomyelin-induced dendritic spine anomalies in a mouse model for Niemann Pick disease type A”. (2014) EMBO Mol Med 6(3):398-413

 

E. Gabandé-Rodriguez, P. Boya, V. Labrador, C.G. Dotti, M.D. Ledesma. High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A. (2014) Cell Death & Diff. 21:864-875.

 

A. Franco-Villanueva, E. Fernández-López, E. Gabandé-Rodríguez, I. Bañón-Rodríguez, J.A. Esteban, I.M. Antón, M.D. Ledesma. WIP modulates dendritic spine actin cytoskeleton by transcriptional control of lipid metabolic enzymes. (2014) Hum. Mol. Genet. 15:4383-4395.

 

 


 

Doctoral Theses:

Cristian Galván. “Participación de la esfingomielina y el colesterol en el establecimiento de la polaridad neuronal. Implicaciones en la enfermedad de Niemann Pick tipo A”. Universidad Nacional de Córdoba, Argentina. 2008.

Estefanía Fernández López. "Influencia de WIP en el citoesqueleto de actina y la composición lipídica de las espinas dendríticas". Universidad Autónoma Madrid. June 2013

Enrique Gabandé Rodríguez. "Alteraciones de la autofagia mediadas por la acumulación de esfingomielina en la enfermedad de Niemann Pick tipo A". Universidad Autónoma Madrid. July 2014

 


 

Patents:

M.D.Ledesma, C.G.Dotti. Methods and compositions for treatment of Alzheimer’s disease by enhancing plasmin or plasmin-like activity”. No. 09/502,448/ 2000

A.I. Arroyo, P.G. Camoletto, M.D. Ledesma. Method for the treatment of Niemann Pick disease type A and related neurological disorders through the activation of neutral sphingomyelinase. Application number P201131297/  July 2011

 

 

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand

COOKIES POLICY

What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers: